HEALTH OF WOMAN. 2016.3(109):99–102

The menstrual cycle and its relationship with systemic inflammation

Gopchuk E. N., Gerasimova T. V.

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev

The onset of menstruation is usually associated with a sharp drop in the level of hormones – estrogen and progesterone after regression of the corpus luteum. It has now been found that this reduction of progesterone – a trigger mechanism of degradation / rejection and parallel repair processes subsequent functional layer endometrial – in the endometrium, these processes can be described as hypoxia, and inflammation. The use of NSAIDs remains etiopathogenic importance in the therapy disoders associated with menstruation – primary and secondary dysmenorrhea.

Key words: menstruation, dysmenorrhea, inflammation, NSAIDs, gynecology.

REFERENCES

1. Dzyak GV, Viktorov AP, Grishina EI. 2009. Nesteroidnyie protivovospalitelnyie preparatyi. K.

2. Elizavetina GA. 2011. Ratsionalnyiy podhod k vyiboru spazmolitikov dlya kupirovaniya abdominalnoy boli. Effektivnaya farmakoterapiya 1:67.

3. Klinicheskaya farmakologiya: V 2 t. Pod red. IA Zupanets, SV Naletova, AP Viktorova. H. 2005.

4. Kovalenko V, Shuba N, Galitskaya A i soavt. 2011. Preparat nimesil R – rastvorimaya forma selektivnogo ingibitora TsOG-2 v lechenii pervichnoy dismenorei. LIki UkraYini. 78:41–42.

5. Lemina EYu, Churyukanov VV. 2005. Tsentralnyiy komponent boleutolyayuschego deystviya nesteroidnyih protivovospalitelnyih sredstv. Eksp. klinich. farmakol. 58;4:59–62.

6. Leonova MV. 2011. Klinicheskaya farmakologiya No-shpa. Metodicheskoe posobie. M.

7. Nasonov EL. 2013. Primenenie nesteroidnyih protivovospalitelnyih preparatov i ingibitorov tsiklooksigenazyi-2 v nachale HHI veka. Ros. med. zhurnal. 11;7:31–43.

8. Nasonov EL. 2001. Effektivnost i perenosimost nesteroidnogo protivovospalitelnogo preparata nimesulid: novyie dannyie. Ros. med. zhurnal. 9;15.

9. Selyuk MN, Kozachok NN, Selyuk OV. 2013. Novyie grani klassicheskogo nesteroidnogo protivovospalitelnogo sredstva diklofenak. Mistetstvo lIkuvannya 8:35–40.

10. Uvarova EV, Tatochenko NM, Gaynova IG, Kudryakova TA. 2001. Lechenie dismenorei u devushek preparatom Logest. Ginekologiya 3(3):99–101.

11. Baerwald A, Adams G, Pierson R. 2003. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 80:116–122. http://dx.doi.org/10.1016/S0015-0282(03)00544-2

12. Berbic M, Ng CH, Fraser IS. 2014. Inflammation and endometrial bleeding. Climacteric. 17:47–53. http://dx.doi.org/10.1016/S0015-0282(03)00544-2

13. Burian M, Geisslinger G. 2005. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol. Ther. 107:139–154. http://dx.doi.org/10.1016/j.pharmthera.2005.02.004; PMid:15993252

14. Clancy Kathryn, Raerwald Angleka, Pierson Roger. 2013. Systemic Inflammation Is Associated with Ovarian Follicular Dynamics during the Human Menstrual Cycle. PLoS ONE. 8:5.

15. Coussons-Read. 2007. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain, Behavior and Immunity. 21:343–350. http://dx.doi.org/10.1016/j.bbi.2006.08.006; PMid:17029703

16. Critchley HO, Maybin JA, Hirani N, Brown P, Jabbour HN. 2011. The Regulation of Vascular Endothelial Growth Factor by Hypoxia and Prostaglandin F2б during Human Endometrial Repair. J Clin Endocrinol Metab. 96:2475–2483. http://dx.doi.org/10.1210/jc.2010-2971; PMid:21677035 PMCid:PMC3380090

17. Graziotti A. 2012, October 7–12. Menstrual bleeding: pathophisiology and comorbidity. 2012 International Federation of Gynecology and Obstetrics World Congress of Gynecology & Obstetrics. Roma, Italy.

18. Jilma B, Dirnberger E, Lцscher I, Rumplmayr A, Hildebrandt J et al. 1997. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. The Journal of laboratory and clinical medicine 130:69.

19. Noguchi K, Okubo M. 2011. Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain. Biol Pharm Bull. 34(8):1163–9. http://dx.doi.org/10.1248/bpb.34.1163; PMid:21804200

20. Thomas SL. 2000. Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet. 355;9207:922–924.

21. Vanden Brink H, Chizen D, Robertson D, Hale G, Burger H et al. 2012. Major Follicle Wave Dynamics across the Reproductive Lifespan: Morphologic and Endocrinologic Characteristics. Ottawa, ON.